Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01090687 · ClinicalTrials.gov registry record

Role of 3D Tomography in Breast Cancer

A clinical trial of Breast Cancer, sponsored by University of Rochester.

Completed
Registry status
150
Enrollment target
1
Study location

NCT01090687 is a study of Breast Cancer that has completed, run by University of Rochester. The registered enrollment target is 150 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01090687, a study of Breast Cancer, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this pilot study is to define the role of dedicated cone beam breast computed tomography in breast cancer imaging. This research is a prelude of a more comprehensive clinical trial that may follow.

Conditions Studied

Interventions

  • RADIATION computed tomography (CT scan)
  • DEVICE computed tomography (CT scan)

Study Locations (1)

New York

  • University of Rochester Medical Center, Highland Breast Imaging Center - Rochester

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2010-03
Est. Completion 2012-11

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT01090687

The ClinicalTrials.gov registry entry for NCT01090687 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which computed tomography (CT scan) is the first listed.

NCT01090687 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01090687 about?

NCT01090687 is a clinical study titled "Role of 3D Tomography in Breast Cancer". The primary aim of this pilot study is to define the role of dedicated cone beam breast computed tomography in breast cancer imaging. This research is a prelude of a more comprehensive clinical trial that may follow.

What is the current status of trial NCT01090687?

This trial is currently completed. The enrollment target is 150 participants. The study started on 2010-03. Estimated completion is 2012-11.

What conditions does trial NCT01090687 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT01090687?

The interventions under investigation include: computed tomography (CT scan) (RADIATION), computed tomography (CT scan) (DEVICE).

Who is sponsoring clinical trial NCT01090687?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01090687 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.